Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.
WuXi AppTec Co., Ltd. has revised the terms of reference for its Remuneration and Appraisal Committee to enhance its corporate governance structure. The committee is tasked with evaluating the performance of directors and senior management, determining remuneration policies, and advising on share incentive plans, which are crucial for aligning management incentives with company goals and improving operational efficiency.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing comprehensive laboratory and manufacturing services that support drug development and production. The company focuses on enabling global pharmaceutical, biotech, and medical device organizations to advance their research and bring new therapies to market.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.